Mirum's Livmarli meets primary goal in phase 3 trial for itch with rare liver diseases
Mirum's Livmarli meets primary goal in phase 3 trial for itch with rare liver diseases
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.